Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021;23(9):E745-749. doi:
10.1001/amajethics.2021.745.
Dr Charles Binkley joins Ethics Talk to discuss his article, coauthored with Michael Politz and Dr Brian Green: "Who, If Not the FDA, Should Regulate Implantable Brain-Computer Interface Devices?"
Drawing on the film Wonder, this article examines how a narrative of community acceptance offers sustaining relationships for people with unusual facial appearance.
AMA J Ethics. 2019;21(11):E1003-1008. doi:
10.1001/amajethics.2019.1003.
Mandating processes that are not evidence based generates distress among patients and clinicians, so physician advocacy in national, state, and local policymaking is key.
AMA J Ethics. 2020;22(8):E668-674. doi:
10.1001/amajethics.2020.668.
Katelyn G. Bennett, MD and Christian J. Vercler, MD, MA
Plastic surgeons who use patient images for online advertising should ensure informed consent and not exploit the patient-physician relationship for gain.
AMA J Ethics. 2018;20(4):328-335. doi:
10.1001/journalofethics.2018.20.4.ecas1-1804.
Advertising a plastic surgery practice on social media can be ethically fraught, and deceptive online marketing techniques can lead to patients feeling betrayed.
AMA J Ethics. 2018;20(4):372-378. doi:
10.1001/journalofethics.2018.20.4.msoc2-1804.
Plastic surgeons’ use of patient images on social media should conform to the American Society of Plastic Surgeons’ advertising and image use guidelines.
AMA J Ethics. 2018;20(4):379-383. doi:
10.1001/journalofethics.2018.20.4.msoc3-1804.